Suzhou Zhonglian Chemical Pharmaceutical

Suzhou Zhonglian Chemical Pharmaceutical is a prominent pharmaceutical manufacturer based in Suzhou, China, specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. As a subsidiary of the China National Pharmaceutical Group (Sinopharm), the company operates within a robust state-owned industrial framework, focusing on therapeutic areas such as cardiovascular health, metabolic disorders, and infectious diseases. Its manufacturing facilities are GMP-certified and have a strong track record of passing international quality audits, facilitating the export of generic medications to global markets. The company's portfolio includes widely used treatments like Amlodipine and Metformin, reflecting its role as a high-volume supplier of essential medicines. Suzhou Zhonglian integrates advanced chemical synthesis with modern formulation technologies to maintain its competitive position in the generic pharmaceutical industry.